By contrast, OVA/LPS-based model has a complex immune response in the lung that not only enhances type 2 response including IL-13 but also involves type 1 response including IFNγ, and aberrant macrophage activation (27–29), which better reflects the pathological changes in the lung during asthma exacerbation. The gene discussed is IL13; the disease is asthma.